论文部分内容阅读
目的探讨危重症患者强化治疗期间的血糖规范监测的临床应用效果。方法回顾性分析自2003年1月～2005年12月和2006年1月～2007年12月两阶段实施危重症患者血糖异常及胰岛素强化治疗监测管理情况。结果75例血糖监测没有规范管理的危重症患者中,13例血糖未能有效控制,5例出现低血糖反应,3例出现低血糖昏迷,血糖控制不良(包括血糖过高、低血糖反应、低血糖昏迷)发生率为28.0%;82例血糖监测规范管理的危重症患者中,1例血糖未控制,2例出现低血糖反应,无低血糖昏迷,血糖控制不良发生率为3.65%。结论危重症患者应实施规范血糖及胰岛素强化治疗监测记录,以减少血糖控制不良发生。
Objective To explore the clinical application of blood glucose monitoring during the intensive treatment of critically ill patients. Methods A retrospective analysis of the management of critically ill patients with glycemic abnormality and insulin-intensive therapy from January 2003 to December 2005 and January 2006 to December 2007 was conducted. Results Seventy-five patients with critically ill patients whose glycemic monitoring was not regulated were unable to effectively control blood glucose, 5 had hypoglycemic reaction, 3 had hypoglycemic coma and had poor glycemic control (including hyperglycemia, hypoglycemia, low One case of critically ill patients under control of blood glucose monitoring, two cases of hypoglycemic reactions, no hypoglycemic coma, and the incidence of poor glycemic control was 3.65%. Conclusion Critically ill patients should be monitored by standardized blood glucose and insulin monitoring records to reduce the incidence of poor glycemic control.